The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases

被引:50
|
作者
Wojcik-Cichy, Kamila [1 ]
Koslinska-Berkan, Ewa [1 ]
Piekarska, Anna [1 ]
机构
[1] Med Univ Lodz, Dept Infect Dis & Hepatol, 1-5 Kniaziewicza St, PL-91347 Lodz, Poland
关键词
non-alcoholic fatty liver disease; ischaemic heart disease; atherosclerosis;
D O I
10.5114/ceh.2018.73155
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries and is associated with obesity, dyslipidaemia, diabetes, and metabolic syndrome. Atherosclerosis and cardiovascular diseases are also highly prevalent in this group of patients, due to the presence of shared risk factors. The incidences of coronary artery calcification, hypertension, aortic valve sclerosis, diastolic dysfunction, atherosclerotic plaques, and increased carotid intima-media thickness were more common in patients with NAFLD than in those without. The present paper reviews the medical literature concerning the association between NAFLD and cardiovascular events.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [1] NAFLD and cardiovascular risk
    Wong, Vincent Wai-Sun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 46 - 47
  • [2] NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
    Targher, Giovanni
    Corey, Kathleen E.
    Byrne, Christopher D.
    [J]. DIABETES & METABOLISM, 2021, 47 (02)
  • [3] CARDIOVASCULAR DISEASES (ATHEROSCLEROSIS)
    DOCK, W
    [J]. ANNUAL REVIEW OF MEDICINE, 1959, 10 : 77 - 92
  • [4] NAFLD and cardiovascular diseases: a clinical review
    Philipp Kasper
    Anna Martin
    Sonja Lang
    Fabian Kütting
    Tobias Goeser
    Münevver Demir
    Hans-Michael Steffen
    [J]. Clinical Research in Cardiology, 2021, 110 : 921 - 937
  • [5] NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
    Chen, Bing
    Tang, W. H. Wilson
    Rodriguez, Mario
    Corey, Kathleen E.
    Sanyal, Arun J.
    Kamath, Patrick S.
    Bozkurt, Biykem
    Virk, Hafeez Ul Hassan
    Pressman, Gregg S.
    Lazarus, Jeffrey, V
    El-Serag, Hashem B.
    Krittanawong, Chayakrit
    [J]. SEMINARS IN LIVER DISEASE, 2022, 42 (04) : 465 - 474
  • [6] NAFLD and cardiovascular diseases: a clinical review
    Kasper, Philipp
    Martin, Anna
    Lang, Sonja
    Kuetting, Fabian
    Goeser, Tobias
    Demir, Muenevver
    Steffen, Hans-Michael
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (07) : 921 - 937
  • [7] NAFLD and risk of cardiovascular disease
    Leake I.
    [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16 (12) : 706 - 706
  • [8] Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) study
    Folsom, Aaron R.
    Alonso, Alvaro
    Misialek, Jeffrey R.
    Michos, Erin D.
    Selvin, Elizabeth
    Eckfeldt, John H.
    Coresh, Josef
    Pankow, James S.
    Lutsey, Pamela L.
    [J]. AMERICAN HEART JOURNAL, 2014, 168 (03) : 296 - 302
  • [9] Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Amedeo Lonardo
    Giovanni Targher
    [J]. Digestive Diseases and Sciences, 2020, 65 : 1593 - 1595
  • [10] Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Lonardo, Amedeo
    Targher, Giovanni
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (06) : 1593 - 1595